Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Sinovac Biotech (SVA) Institutional Ownership

Sinovac Biotech logo

Institutional Ownership Changes (13F Filings) for Sinovac Biotech (NASDAQ:SVA)

Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$39.30M
Number of
Institutional Sellers
(last 12 months)
0
Get SVA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sinovac Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SVA Institutional Buying and Selling by Quarter

Sinovac Biotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Bank of America Corp DE5,886$38K0.0%N/A0.006%
8/14/2025 Vivo Capital LLC5,903,000$38.19M3.9%N/A5.924%
8/14/2025 California Public Employees Retirement System68,732$445K0.0%N/A0.069%
8/13/2025 Skandinaviska Enskilda Banken AB publ 40,000$259K0.0%N/A0.040%
8/11/2025 Spark Investment Management LLC29,100$188K0.5%N/A0.029%
8/8/2025 Geode Capital Management LLC27,717$179K0.0%N/A0.028%
4/22/2024Vivo Capital LLC11,800,000$76.35M6.0%N/A0.000%
10/26/2023Yorktown Management & Research Co Inc149,786$969K1.1%+100.0%0.151%
7/28/2023Yorktown Management & Research Co Inc74,893$291K0.3%N/A0.075%
8/12/2021Eqis Capital Management Inc.17,879$116K0.0%-48.8%0.018%
(Data available from 1/1/2016 forward)

SVA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SVA shares?

During the previous two years, the following institutional investors and hedge funds held shares of Sinovac Biotech shares: Vivo Capital LLC ($38.19M), Yorktown Management & Research Co Inc ($969K), California Public Employees Retirement System ($445K), Skandinaviska Enskilda Banken AB publ ($259K), Spark Investment Management LLC ($188K), and Geode Capital Management LLC ($179K), and Bank of America Corp DE ($38K).Learn more on Sinovac Biotech's institutional investors.

Which institutional investors have been buying Sinovac Biotech's stock?

The following institutional investors have purchased Sinovac Biotech's stock in the last 24 months: Vivo Capital LLC ($17.70M), Yorktown Management & Research Co Inc ($74.89K), California Public Employees Retirement System ($68.73K), Skandinaviska Enskilda Banken AB publ ($40K), Spark Investment Management LLC ($29.10K), Geode Capital Management LLC ($27.72K), and Bank of America Corp DE ($5.89K).

How much institutional buying is happening at Sinovac Biotech?

Institutional investors have bought a total of 6,074,435 shares in the last 24 months. This purchase volume represents approximately $39.30M in transactions.



This page (NASDAQ:SVA) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners